logo-loader
NASDAQ:NMRD

Nemaura Medical Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$183.05 m
Price
$0.88
Change
2.33%
52 weeks high
3.35
52 weeks low
0.70

In brief

Nemaura Medical Inc. is a medical technology company which has developed sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) designed to improve glucose management for all people with diabetes and pre-diabetics. SugarBEAT® consists of a daily-disposable adhesive skin-patch connected to a rechargeable transmitter, with an app displaying glucose readings at five-minute intervals for periods of up to 24 hours. Nemaura was founded in 2009 and is headquartered in Loughborough, United Kingdom.